Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing Saccharomyces to a Mixture of Lactobacillus, Bifidobacterium, and Saccharomyces

Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing Saccharomyces to a Mixture of Lactobacillus, Bifidobacterium, and Saccharomyces

Objective: Most infections with Enterobacteriaceae producing AmpC β-lactamase (AmpC)-, extended-spectrum β-lactamase (ESBL)-, and carbapenemase-producing bacteria, vancomycin-resistant Enterococcus as well as naturally resistant non-fermenting bacteria such as Pseudomonas aeruginosa, are related to...

Full description

Bibliographic Details
Main Authors: Grégoire Wieërs, Valérie Verbelen, Mieke Van Den Driessche, Ekaterina Melnik, Greet Vanheule, Jean-Christophe Marot, Patrice D. Cani
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Public Health
Subjects:
probiotics
microbiota
antibiotic resistance
prevention
extended-spectrum beta-lactamase
AmpC & [beta]-lactamase
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2020.578089/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2020.578089/full

Similar Items